Two years ago I was asked to see a youth, F. H., aged 19, who had been admitted for hypertension. He had been discharged from the Army because of arthritis diagnosed as rheumatic fever. However, his story was more like gout and he had a tophus on one elbow. Investigations confirmed a high serum urate but also showed a blood urea of 106 mg/100 ml, an inability to concentrate or dilute his urine and failure to concentrate dye for an excretion pyelogram. His kidneys on X-ray were extremely small for his age. Renal biopsy was unsuccessful. His big toes on X-ray showed typical cystic erosions of gout.
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The mildness of his gout and the severity of his renal disease suggested that his gout might not be primary but secondary to renal failure to excrete urates. One way of settling this was to look for evidence of gout or hyperuriciemia in the family, since Stecher et al. (1949) have shown that about 20% of the relatives of patients with primary gout will have symptomless hyperuricimia, whereas this would hardly be expected in the family of a patient with renal disease.
This boy came of a large family and Dr. Howard Duncan and I examined all survivors, including both parents and five surviving siblings, and obtained histological material from the -sister who had died.
We discovered that both parents and all surviving siblings had hyperuricemia, providing strong evidence that our patient had primary gout.
J., aged 60, the father, was well and neither he ncr any of his eleven siblings had had gout. Blood pressure 145/80, blood urea 32 mg/100 ml, serum urate 9 4 mg/100 ml. N., aged 49, the mother, had never had gout, nor had there been gout in her family. She had developed toximia in 2 of her 8 pregnancies and was left with hypertension (blood pressure 230/130), proteinuria and raised blood urea (51 mg/100 ml), serum urate 6-0 mg/100 ml. E., the eldest sister, died aged 14 at another hospital. She had had a systolic blood pressure of 200, with papilleedema, proteinuria and a blood urea of 160 mg/100 ml. The kidneys were small, contracted and granular. On the section available, Professor C. V. Harrison commented that "the picture suggests chronic pyelonephritis. There is also evidence NovEMIBER suggestive of gout in the form of basophilic casts in the second convoluted tubules. These casts contrast with the majority which are eosinophilic".
Na.,-aged 27, sister, had had hypertension (blood pressure 180/120), toxemia and proteinuria in both her pregnancies and she had a raised blood urea (56 mg/100 ml). Her serum urate was 117 mg/100 ml. Her 6-year-old son had a serum urate of 3 5 mg/100 ml. She has subsequently developed acute gouty arthritis.
G., aged 26, the next sister, had had similar toxanmia of pregnancy, a blood urea of 48 mg/100 ml and proteinuria. Blood pressure was 150/100, serum urate 6-5 mg/100 ml. A., aged 23, the eldest brother, was normotensive (blood pressure 120/70) and symptom free, but-had a raised blood urea (53 mg/100 ml) and proteinuria. Serum urate was 7-7 mg/100 ml. D., the next brother, died in infancy.
I., the third brother, was well, but he too had a raised blood urea (50 mg/100 ml), proteinuria and a serum urate of 12-7 mg/100 ml (Table I) There was no abnormal amino-aciduria in the index case, so that it is unlikely that this family is suffering from the familial renal disease recently noted by Wallace and Jones (1960) and there was no evidence of nerve deafness, as in the familial renal disease reviewed by Goldbloom et al. (1957) .
Thus in this family hyperuriciemia exists without renal disease (in the father and youngest son), but renal disease does not exist without hyperuricemia. It appears that hyperuriciemia is the primary defect and renal disease the complication. We have called this condition "hyperuricemic nephropathy" and we have assumed that the high urate concentrations may be damaging to the kidney. We have gone on to examine some of the implications of this idea.
It is difficult to define hyperuricwmic nephropathy in terms of morbid anatomy since there is no single renal picture associated with gout. Nevertheless, the association of renal disease and gout is very common, rising from about 30% in clinical series (including our own) to 100% at autopsy. Three main renal lesions are seen. Firstly, proteinuria, sometimes without other detectable damage and compatible with long life. Secondly, uric acid stones or urate precipitation in the smaller urinary passages. Thirdly, and most commonly, a slowly progressive nephrosclerosis. These types may be complicated by vascular lesions or infection, and the end-result is a chronic Bright's disease without any specific features. If our assumption is correct we might expect to see an increased prevalence of these forms of renal disease in any form of hyperuricmmia, whether primary, secondary or experimental, and whether or not associated with gout. We are not yet in a position to speak of prevalence, but there are indications that this is so from individual examples. Thus Berliner et al. (1950) have shown that experimental urate infusions in man are damaging to the kidneys. They achieved a serum urate level of 26 mg % in one subject, and produced oliguria for two days and a high blood urea for two weeks. Nature produces a similar experiment in acute leuknmia, especially after treatment. We have seen renal disease in secondary gout complicating chronic myeloid leukemia, in polycythimia and in congenital hlmolytic anmmia. We have also seen it complicating similar diseases with hyperuricmmia but without gout. A patient with myeloma and hyperuricEemia had renal disease which was diagnosed as-chronic pyelonephritis. Only in the week before she died did she develop a typical acute attack of gout with discharge of a tophaceous material. Autopsy confirmed a nonspecific "chronic pyelonephritis"; of course, gouty patients may develop renal disease, particularlyurate stones, before their arthritis.
On the other hand, had there been only 5 children instead of 8 in this family, it would have presented as one in which there was a high incidence of renal disorders but no gout, and the common metabolic defect would not have been obvious. It seems quite possible therefore that other patients with familial hyperuricemic nephropathy may present as a variety of renal conditions, such as simple proteinuria, preeclamptic toxemia and the severer forms of renal hypertension.
To sum up, it is possible that hyperuricmmia whether inherited or acquired, and whether associated with gout or not, may be damaging to the kidneys. This leads to the practical difficulty that most of the currently used antihypertensiveH agents, with the possible exception of reserpine, will cause urate retention in the blood. This is especially true of chlorothiazide, but Dr. Howard Duncan and Dr. C. T. Dollery have also shown that similar effects take place with pempidine and mecamylamnine, and we have recently seen it with bretylium and guanethidine. This problem needs further study, since in gouty renal disease with hypertension these drugs may make the underlying trouble worse. However, we have three potent uricosuric agents, probenecid, sulphinpyrazole and Zoxazolamine, with which to correct the metabolic defect, and there is some hope that if given earlv enough they may not only lower serum urate levels but improve renal function (Phillips, 1955 ). This has not proved true in the index patient, who made a partial response to probenecid but relapsed on sulphinpyrazole (Anturan) (Fig. 1 ). However, this patient had advanced renal disease before treatment was started and despite it he developed retinal changes,and increased blood urea. His younger brother (I. H.) has been started on treatment at a much earlier stage. He had had a progressive rise in blood pressure and blood urea in the eighteen months of observation without treatment. He also had further X-ray changes. A recent renal biopsy revealed only very slight fibrosis and atrophy of a few tubules. Kidney function is still good and we are hoping that early and vigorous treatment with probenecid will not only control his gout but halt the progress of his renal disease.
